Membership

Special Interest Groups

Clinical Trials

The purpose of this SIG is to provide a forum to discuss challenges and advances in the methods of conducting clinical trials of analgesics and related agents. The areas of interest within this SIG will include outcomes measurement, biostatistics, clinical pharmacology, bioethics, patient recruitment, electronic data capture, human experimental pain models, proof-of-concept trials, PK-PD modeling, patient recruitment, measurement of tolerance and addiction, psychological aspects of clinical trials, placebo effects, etc.

Chair:
Gus Larijani, PharmD
Director of Anesthesia Research
Cooper University Hospital
Dept of Anesthesiology
One Cooper Plaza
Camden, NJ 08103
larijani-ghassem@cooperhealth.edu
Directors at Large:
Leslie A Tive, PhD
Medical Director
Pfizer Inc
235 E 42nd St
New York, NY 10017
tivel@pfizer.com
 
Nancy Z Olson, MPS CCRC
Analgesic Development Ltd
635 Madison Ave 3rd Fl
New York, NY 10022
analgesicdevel@att.net